Dexin Corporation (TPEX:3349)
Taiwan · Delayed Price · Currency is TWD 23.50
+0.90 (3.98%)
Aug 19, 2026, 1:30 PM CST
Dexin Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 406.85 | 479.32 | 453.99 | 387.42 | 552.01 | 1,231 | |
Revenue Growth | -19.46% | 5.58% | 17.18% | -29.82% | -55.17% | 51.35% |
Cost of Revenue | 351.66 | 383.07 | 367.11 | 345.54 | 474.62 | 996.14 |
Gross Profit | 55.19 | 96.25 | 86.88 | 41.88 | 77.39 | 235.08 |
Selling, General & Admin | 71.29 | 72.41 | 79.23 | 81.76 | 96.15 | 115.4 |
Research & Development | 47.58 | 52.55 | 68.51 | 54.28 | 56.96 | 49.98 |
Operating Expenses | 119.05 | 122.12 | 154.42 | 155.33 | 142.23 | 165.24 |
Operating Income | -63.86 | -25.87 | -67.54 | -113.45 | -64.85 | 69.84 |
Interest Expense | -2.95 | -3.2 | -4.97 | -6.87 | -7.23 | -6.79 |
Interest & Investment Income | 1.51 | 1.15 | 1.52 | 2.22 | 0.79 | 0.11 |
Earnings From Equity Investments | -4.19 | -0.61 | -0.43 | -2.49 | -1.4 | 0.56 |
Currency Exchange Gain (Loss) | 24.56 | -9.95 | 13.97 | -0.24 | 18.21 | -4.98 |
Other Non Operating Income (Expenses) | 10.13 | 9.9 | 10.78 | 9.42 | 8.57 | 11.83 |
EBT Excluding Unusual Items | -34.79 | -28.57 | -46.67 | -111.41 | -45.9 | 70.57 |
Gain (Loss) on Sale of Assets | - | - | -3.81 | - | 0.15 | 0.17 |
Asset Writedown | -11.99 | -11.99 | - | - | - | - |
Other Unusual Items | 0.05 | 0.05 | 7.16 | 3.16 | 0.01 | 0 |
Pretax Income | -46.72 | -34.72 | -43.32 | -108.25 | -45.75 | 70.74 |
Income Tax Expense | 8.13 | 9.17 | -1.16 | -13.47 | 5.02 | 10.58 |
Net Income | -54.85 | -43.89 | -42.16 | -94.78 | -50.76 | 60.16 |
Net Income to Common | -54.85 | -43.89 | -42.16 | -94.78 | -50.76 | 60.16 |
Net Income Growth | - | - | - | - | - | 181.38% |
Shares Outstanding (Basic) | 46 | 43 | 40 | 40 | 39 | 35 |
Shares Outstanding (Diluted) | 46 | 43 | 40 | 40 | 39 | 35 |
Shares Change | 14.38% | 6.89% | - | 2.61% | 10.01% | 0.21% |
EPS (Basic) | -1.20 | -1.02 | -1.05 | -2.37 | -1.30 | 1.70 |
EPS (Diluted) | -1.20 | -1.02 | -1.05 | -2.37 | -1.30 | 1.69 |
EPS Growth | - | - | - | - | - | 179.47% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 59.46 | 71.81 | -60.67 | -88.11 | -12.27 | 84.17 |
Free Cash Flow Per Share | 1.30 | 1.68 | -1.51 | -2.20 | -0.31 | 2.37 |
Dividend Per Share | - | - | - | - | - | 0.769 |
Dividend Growth | - | - | - | - | - | 389.31% |
Gross Margin | 13.56% | 20.08% | 19.14% | 10.81% | 14.02% | 19.09% |
Operating Margin | -15.70% | -5.40% | -14.88% | -29.28% | -11.75% | 5.67% |
Profit Margin | -13.48% | -9.16% | -9.29% | -24.46% | -9.20% | 4.89% |
Free Cash Flow Margin | 14.61% | 14.98% | -13.36% | -22.74% | -2.22% | 6.84% |
EBITDA | -47.62 | -9.06 | -50.78 | -97.81 | -50.38 | 83.11 |
EBITDA Margin | -11.71% | -1.89% | -11.19% | -25.25% | -9.13% | 6.75% |
D&A For EBITDA | 16.24 | 16.81 | 16.76 | 15.64 | 14.46 | 13.27 |
EBIT | -63.86 | -25.87 | -67.54 | -113.45 | -64.85 | 69.84 |
EBIT Margin | -15.70% | -5.40% | -14.88% | -29.28% | -11.75% | 5.67% |
Effective Tax Rate | - | - | - | - | - | 14.96% |